Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma.

被引：29

作者：

Atkins, Michael B.

Reiney, Ragini

Sznol, Kudchadkar Mario

McDermott, David F.

Lotem, Michal

Schachter, Jacob

Wolchok, Jedd D.

Urba, Walter John

Kuzel, Timothy

Schuchter, Lynn Mara

Slingluff, Craig L.

Ernstoff, Marc S.

Fay, Joseph W.

Friedlander, Philip Adam

Gajewski, Thomas

Zarour, Hassane M.

Rotem-Yehudar, Rinat

Sosman, Jeffrey Alan

机构：

[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA

[2] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[3] Yale Univ, New Haven, CT USA

[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[5] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel

[6] Tel Aviv Univ, Ella Inst Res & Treatment Melanoma, Sheba Med Ctr, Sackler Fac Med, Ramat Gan, Israel

[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[8] Earle A Chiles Res Inst, Portland, OR USA

[9] Providence Canc Ctr, Portland, OR USA

[10] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[11] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[12] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA

[13] Norris Cotton Canc Ctr, Dartmouth Hitchcock Med Ctr, Lebanon, NH USA

[14] Baylor Med Ctr, Dallas, TX USA

[15] Mt Sinai Med Ctr, Ruttenberg Canc Clin, New York, NY 10029 USA

[16] Univ Chicago, Chicago, IL 60637 USA

[17] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

[18] CureTech Ltd, Yavne, Israel

[19] Vanderbilt Univ, Med Ctr, Nashville, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.9001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

9001

引用

页数：1